By Market & Region

Houston – September 13, 2026 -- Flotek Industries (NYSE: FTK) raised its full-year 2026 revenue guidance to a range of $360 million to $370 million, up from the $340 million to $350 million forecast issued just weeks earlier, citing surging international chemistry sales tied to work in Saudi Arabia.

Flotek lifts EBITDA outlook to $50-54 million after second guidance revision in five weeks

The company also raised its Adjusted EBITDA guidance to $50 million to $54 million, up from the $47 million to $51 million range announced on August 4, 2026. At the midpoints of the new ranges, Flotek's 2026 total revenue would grow 54% and Adjusted EBITDA would grow 58% compared with reported full-year 2025 figures.

Chandler – September 13, 2026 -- VIAVI Solutions Inc. (NASDAQ: VIAV) will present a full-stack data center test portfolio at booth 1001 during ECOC 2026, running September 21-23 at the FYCMA exhibition center in Malaga, Spain.

Hyperscalers push 1.6T rollouts while planning for 3.2T networks

Cloud providers are deploying 1.6T technologies within racks, across clusters and between data centers as AI infrastructure scales, with 3.2T architectures already in planning. These builds depend on 16x224G and 8x448G lane designs enabled by Silicon Photonics, Co-packaged Optics (CPO) and dense optical connectivity, driving sharp growth in fiber density and multifiber interconnects.

Wellesley Hills, Mass. – – September 13, 2026 -- Cure Alzheimer's Fund (CureAlz) has appointed Drs. Michelle Arkin, Ronald B. DeMattos, Donna M. Huryn, and Kalpana Merchant to its Scientific Advisory Board (SAB), adding decades of pharmaceutical drug-discovery experience to the nonprofit's research-funding strategy.

Board addition brings direct experience from an FDA-cleared Alzheimer's drug

Ronald B. DeMattos spent more than 20 years in neuroscience discovery at Eli Lilly, most recently as Senior Vice President and Chief Scientific Officer for Neurobiologics, where he led development of candidates that advanced to clinical studies including donanemab, the FDA-cleared amyloid-lowering antibody marketed as Kisunla for early Alzheimer's disease.

Wilmington, Massachusetts – – September 13, 2026 -- Stafford Manufacturing Corp. has released a full line of shaft collars, couplings, and flange mounts engineered specifically for conveyor and packaging equipment in the food and beverage sector, targeting operators that require frequent wash-down cycles under USDA and FDA compliance standards.

New product line fits round, square and hex bores across multiple materials

The Stafford Shaft Collars, Couplings & Flange Mounts are machined from 303 and 316 stainless steel, food-grade Blue Acetal, Nylon, or Delrin, paired with 18-8 or 316 stainless steel fasteners. The components are available in one- and two-piece designs, giving equipment manufacturers flexibility for assembly and maintenance without full shaft disassembly.

San Bruno, Calif. – September 13, 2026 -- Chariot Defense, a maker of software-defined power distribution systems for the battlefield, has appointed four defense and venture capital veterans to its Board of Advisors, following a $34 million Series A round led by Andreessen Horowitz and a $7.4 million contract with the Pentagon's Department of War Innovation Unit (DIU).

Abu Dhabi – September 13, 2026 -- Robo.ai Inc. (Nasdaq: AIIO) said its industrial group Alif Holding plans to establish Alif Maritec, a wholly owned subsidiary dedicated to marine security and intelligent maritime infrastructure in the United Arab Emirates.

Alif Holding designates Dr. Jasem Al-Mansory as chairman of new maritime unit

Dr. Jasem Al-Mansory, Chief Executive Officer of Alif Holding, is expected to serve as Chairman of Alif Maritec once it is formally established. The subsidiary will target four business areas: maritime protection, smart ports, underwater intelligence and critical infrastructure protection, serving governments and infrastructure operators managing ports, coastlines and offshore energy assets.

Los Angeles – September 13, 2026 -- Hermeus is developing Ramjet-X, an expendable, ramjet-powered test vehicle designed to be launched from its reusable Quarterhorse aircraft, aiming to make high-Mach airbreathing flight testing cheaper and more repeatable.

Quarterhorse aircraft eliminates need for costly disposable boosters

Ramjet engines require substantial initial speed before they can operate, historically forcing test programs to rely on large, expensive, single-use boosters. Hermeus instead uses its reusable Quarterhorse aircraft to accelerate Ramjet-X to the required speed and altitude before release, after which the vehicle enters ramjet-powered flight while Quarterhorse returns for subsequent missions.

Unterföhring – – September 13, 2026 -- Germany's women's basketball team reached its first-ever FIBA World Cup quarterfinal after a 94-56 win over South Korea at the home tournament, setting up a broadcast showcase for ProSieben MAXX. The German broadcaster will air the quarterfinal against reigning European champions Belgium live on Thursday, September 10, with coverage starting at 17:15 and tip-off at 17:45.

Belgium enters the matchup unbeaten in the tournament

Belgium, ranked among the strongest teams in the field, has not lost a game at the 2026 FIBA Basketball World Cup, raising the stakes for the German side's historic quarterfinal debut.

ProSieben MAXX deploys its established 'ran Basketball' broadcast team

Presenter Christoph Dommisch, Olympic champion Sonja Greinacher, and commentator Matthias Killing will provide on-site coverage of the match as part of the network's ongoing home World Cup broadcast slate.

Benghazi -- The University of Benghazi resumed full operations on September 4, 2026, after an 11-year closure caused by war damage, following a three-year reconstruction led by the Libyan Development and Reconstruction Fund under Director General Belqasim Khalifa Haftar.

Reconstruction rebuilds an integrated university city in three years

The project restored the Faculties of Engineering, Humanities, Law, Science and Languages, along with the central library, teaching and administrative buildings, laboratories, utility facilities, student dormitories, internal roads and supporting infrastructure. The University of Benghazi, known as the "Mother of Libyan Universities," serves nearly 100,000 students and had been shuttered since sustaining extensive destruction during the Libyan armed forces' conflict with terrorist groups.

Hong Kong – September 12, 2026 -- SANY Heavy Industry (600031.SH) reported first-half 2026 revenue of approximately $7.89 billion, up 19.49% year-on-year, with attributable net profit rising 9.13% to $838.887 million.

Second-quarter revenue growth outpaces first-half rate at 24.39%

Q2 revenue reached $4.328 billion, exceeding the H1 growth rate, while attributable net profit for the quarter climbed 16.93% to $473.108 million. Operating cash flow totaled $1.440 billion. As of June 30, total assets stood at $26.708 billion and equity at $13.576 billion.

Almaty – September 11, 2026 -- The Bulat Utemuratov Foundation has allocated 460 million tenge (approximately $1 million) to fund the gasification of private housing in Almaty, partnering with the city's Akimat to expand urban infrastructure and cut winter air pollution.

Foundation and city sign MoU covering inspections, consultations and gas connections

Under the recently signed memorandum of understanding, the Almaty Akimat will conduct inspections of private homes, advise residents on connection procedures and provide end-to-end support for switching to natural gas heating. Licensed contractors will then carry out the required construction and installation work.

Arlington, Va. – September 11, 2026 -- Air, the Enterprise Readiness company, has appointed Andrej Danko as Chief Product and Technology Officer to lead engineering and product strategy for its AI-native platform serving the national security enterprise.

Danko joins from ServiceNow after leading global public sector AI deployments

Danko previously served as Vice President and General Manager of Global Public Sector Product Management at ServiceNow, where he directed agentic AI deployments across the U.S. Defense Logistics Agency, the Department of Homeland Security, and international allies including NATO members, Australia, and Singapore. He brings three decades of software industry experience spanning product management, design, engineering, and corporate strategy, with prior roles at Productboard, Merlon Intelligence, and SAP. Danko holds an MBA from MIT Sloan School of Management, plus a Ph.D. and M.S. in Applied Computer Science.

Berlin – September 11, 2026 -- SATELLAI announced an expanded collaboration with Deutsche Telekom IoT and Swift Navigation at IFA 2026, combining artificial intelligence, global IoT connectivity and advanced positioning technology to scale its connected pet-care devices internationally.

Three technology layers merge to support global pet-tech rollout

The partnership pairs SATELLAI's AI-driven pet intelligence with Deutsche Telekom IoT's global connectivity infrastructure and Swift Navigation's location technology. SATELLAI unveiled the deepened collaboration during a keynote at an exclusive networking and showcase event hosted by Deutsche Telekom IoT.

Swift Navigation upgrades boost location accuracy for connected collars

The collaboration has improved location capabilities on SATELLAI's connected pet devices, enabling more reliable GPS-based features including virtual perimeters, route history tracking and escape alerts.

Carmiel, Israel – September 11, 2026 -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) confirmed that Chief Financial Officer Gilad Mamlok will represent the company at two investor conferences in New York City this month.

Mamlok addresses H.C. Wainwright's 28th Annual Global Investment Conference on September 14

The presentation is scheduled for 2:00 p.m. EDT during the three-day event running September 14-16, 2026.

Morgan Stanley's 24th Annual Global Healthcare Conference hosts a fireside chat on September 16

The session is set for 1:05 p.m. EDT and will be streamed via a live audio webcast, with an archived replay available afterward on Protalix's investor relations site.

Hsinchu – September 11, 2026 -- Spirox Corporation (TWSE: 3055) unveiled its SP7000G high-speed TGV crack inspection system, a tool designed to support mass production testing of glass substrates for next-generation AI and HPC packaging.

Spirox scans a full 510mm by 515mm glass substrate in under 20 minutes

The SP7000G detects internal micro-cracks after metallization and ABF build-up processes, according to the company. Spirox positions the system to improve inspection efficiency, monitor process quality and defect distribution, and optimize yield as Through Glass Via (TGV) technology moves toward volume manufacturing.

Mainz – September 12, 2026 -- Public libraries across Rhineland-Palatinate will offer free coding instruction to children aged four to seven starting this autumn, under a new partnership between the state's Landesbibliothekszentrum (LBZ) and German public broadcasters WDR and SWR.

Library staff train in September ahead of autumn rollout

Training sessions for participating library staff run from September 21 to 23, 2026, preparing personnel to guide children through the program before public sessions begin in autumn 2026.

Vienna – September 12, 2026 -- Julius Meinl named Elizaveta Rîmscaia of Moldova as Overall Champion of its International Barista Cup 2026 Grand Finale, held September 4 at Vienna's MuseumsQuartier, capping a global competition that drew more than 350 applicants across 15 countries.

Fifteen national champions competed across three judged disciplines

Baristas from markets including Austria, Italy, Germany, China, Georgia and Croatia advanced through national rounds to Vienna's finale, where an independent international jury scored competitors on Espresso, Cappuccino and Signature Drink categories.

Salt Lake City – September 12, 2026 -- Sorenson has appointed Scott Cederbaum as Head of Marketing, effective August 10, 2026, tasking him with leading the company's global brand, demand generation and customer lifecycle strategy as accessibility technology and AI converge.

Cederbaum joins with two decades of revenue and growth leadership across education, technology and subscription businesses

He most recently served as Chief Revenue Officer at Blueprint Prep, where he oversaw enterprise-wide revenue strategy, marketing, sales and pricing. Cederbaum has also held CMO and senior growth roles building marketing organizations, running digital transformation initiatives, and using data and analytics to drive customer acquisition and retention.

Istanbul – September 12, 2026 -- Turkish construction group Rönesans has secured a place among the world's top 50 international contractors for the 11th consecutive year, according to Engineering News-Record's 2026 "Top 250 International Contractors" list.

ENR ranking measures overseas revenue, not global scale

The ENR list ranks firms by revenue generated outside their home markets, a metric that reflects a company's ability to win and execute projects internationally rather than its overall size. Rönesans first appeared on the list in 2006 at position 86 and has since climbed into the top 50 bracket, a run it has now sustained for over a decade.

Taipei – September 12, 2026 -- HanchorBio Inc. (TWSE: 7827) said the U.S. Food and Drug Administration has cleared its HCB101 Single-Patient Expanded Access Protocol (HCB101-EA-001) as "safe to proceed," allowing a Phase 1 patient who showed clinical benefit to continue receiving the investigational drug beyond the parent trial.

FDA authorizes continued treatment for a single Phase 1 patient

The clearance permits the patient to keep receiving HCB101 outside the standard clinical trial structure under the FDA's Expanded Access, or compassionate use, framework. The agency's review weighed the patient's clinical circumstances, including whether the potential benefit justified the risks given the severity of the disease. HanchorBio noted the determination applies only to this individual-patient protocol and does not constitute approval of HCB101 or an FDA finding on its broader safety or efficacy.